Circumvent
Daniel Chelsky is a seasoned professional in the fields of biochemistry and life sciences, currently serving as a Strategic Advisor at JLL Partners and the Chief Scientific Officer at Circumvent since December 2020. With extensive experience in leadership roles, Chelsky has also held the position of Senior Consultant at Spectragen Informatics, LLC since July 2018 and was the Chief Scientific Officer at Caprion Biosciences from 2002 to 2019. Prior to these roles, Chelsky served as President of the BioSignal subsidiary at PerkinElmer and as Senior Director of Biology at Pharmacopeia. Chelsky earned a Ph.D. in Biochemistry from the University of Oregon and a B.Sc. in Chemistry from UC Santa Barbara.
This person is not in any teams
This person is not in any offices
Circumvent
Circumvent Pharmaceuticals is seeking to address the significant unmet need of neurodegenerative disease patients. Circumvent is targeting heritable forms of neurodegeneration to enable drug discovery and development in both rare and common forms of neurodegenerative disease.